Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.47 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | FABP3 | P05413 | 5/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28502572 | 1.00 | FAAH (0.48) | FAAHTRPV1EPHX2PPARAFABP3 | |
| SCHEMBL3850070 | 1.00 | FAAH (0.48) | FAAHTRPV1EPHX2PPARAFABP3 | |
| SCHEMBL29086469 | 1.00 | FAAH (0.48) | FAAHTRPV1EPHX2PPARAFABP3 | |
| SCHEMBL10589258 | 1.00 | FAAH (0.48) | FAAHTRPV1EPHX2PPARAFABP3 | |
| SCHEMBL2385059 | 1.00 | FAAH (0.48) | FAAHTRPV1EPHX2PPARAFABP3 | |
| SCHEMBL8335717 | 1.00 | FAAH (0.48) | FAAHTRPV1EPHX2PPARAFABP3 | |
| SCHEMBL6387902 | 1.00 | FAAH (0.48) | FAAHTRPV1EPHX2PPARAFABP3 | |
| SCHEMBL18300982 | 1.00 | FAAH (0.48) | FAAHTRPV1EPHX2PPARAFABP3 | |
| SCHEMBL18298141 | 1.00 | FAAH (0.48) | FAAHTRPV1EPHX2PPARAFABP3 | |
| SCHEMBL2385093 | 1.00 | FAAH (0.48) | FAAHTRPV1EPHX2PPARAFABP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022074962-A1 | AQUEOUS BIODEGRADABLE-RESIN DISPERSION, PRODUCTION METHOD THEREFOR, AND FOOD-PACKAGING PAPER OBTAINED USING AQUEOUS BIODEGRADABLE-RESIN DISPERSION | ミヨシ油脂株式会社 | 2022-04-14 | — | — | WO | claimed |
| JP-10310511-A | — | — | None | — | — | JP | disclosed |
| JP-4328200-A | — | — | None | — | — | JP | disclosed |
| EP-4704853-A1 | METHOD OF TREATING OPERATIVE COMPLICATIONS OF CATARACT SURGERY | Formosa Pharmaceuticals, Inc. (TW) | 2026-03-11 | — | — | EP | disclosed |
| WO-2025089232-A1 | SECOND AGENT COMPOSITION FOR HAIR COSMETIC AGENT, HAIR COSMETIC AGENT, AND HAIR COSMETIC KIT | ホーユー株式会社 | 2025-05-01 | — | — | WO | disclosed |
| EP-4536395-A1 | CLAY COMPOSITE SUPPORT-ACTIVATORS AND CATALYST COMPOSITIONS | Formosa Plastics Corporation, U.S.A. (US) | 2025-04-16 | — | — | EP | disclosed |
| WO-2025069857-A1 | HAIR COSMETIC COMPOSITION AND PRODUCTION METHOD THEREFOR | ライオン・スペシャリティ・ケミカルズ株式会社 | 2025-04-03 | — | — | WO | disclosed |
| US-20250090437-A1 | COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF | MIYOSHI YUSHI KK (JP) | 2025-03-20 | — | — | US | disclosed |
| JP-2025009964-A | DENTIN PROTECTANT AND ORAL COMPOSITION | サンスター株式会社 | 2025-01-20 | — | — | JP | disclosed |
| WO-2024262353-A1 | COMPOSITION FOR ORAL CAVITY | ライオン株式会社 | 2024-12-26 | — | — | WO | disclosed |
| EP-0651632-A1 | HAIR COSMETIC COMPOSITION. | KAO CORP (JP) | 1995-05-10 | — | — | EP | disclosed |
| EP-0479292-B1 | Process for producing aromatic hydroxy compound | KAWASAKI STEEL CO (JP) | 1994-12-14 | — | — | EP | disclosed |
| US-5322946-A | Reacting aromatic sulfonic acid or salt with alkali metal hydroxide in presence of surfactant | KAWASAKI STEEL CORPORATION (JP) | 1994-06-21 | — | — | US | disclosed |
| WO-1994002111-A1 | HAIR COSMETIC COMPOSITION | KAO CORPORATION (JP) | 1994-02-03 | — | — | WO | disclosed |
| JP-H04328200-A | TRANSPARENT SOAP | JIYUNSEI SANGYO KK | 1992-11-17 | — | — | JP | disclosed |
| US-5116608-A | Quaternary ammonium ethyl mercaptan | SEIWA KASEI CO., LTD. (JP) | 1992-05-26 | — | — | US | disclosed |
| EP-0479292-A1 | Process for producing aromatic hydroxy compound | KAWASAKI STEEL CORPORATION (JP) | 1992-04-08 | — | — | EP | disclosed |
| US-5051251-A | Dialkylene glycol monoalkyl ether and a cationic surfactant | KAO CORPORATION (JP) | 1991-09-24 | — | — | US | disclosed |
| EP-0361391-A2 | Permanent waving composition | SEIWA KASEI CO., LTD. (JP) | 1990-04-04 | — | — | EP | disclosed |
| EP-0339498-A2 | Liquid detergent composition | AJINOMOTO CO., INC. (JP) | 1989-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250090437-A1 | COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF | CUTA, HAT1, NACA | FAAH 664/4885TRPV1 80/4885EPHX2 3818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.